Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Search InvestCenter
Recent Quotes
My Watchlist
Indicators
Novartis AG ADS (NY: NVS)
74.36 USD  +0.54 (+0.73%)
Official Closing Price  /  Updated: 6:40 PM EDT, May 24, 2013  /  Add to My Watchlist      
View: Quote News Research
Blog posts about Novartis AG ADS
 
< Previous 1 2 3 4 5 6 7 8 9
...
27 28 Next >
(ARIA) ARIAD Pharmaceuticals Announced Ponatinib Data
December 17, 2012
ARIAD Pharmaceuticals (ARIA) recently announced positive data from the pivotal PACE study on... Visit StockBlogHub to view complete post. Read More
category INFI , QCOR , Biotechnology , and 13 more.
from Stock Blog Hub
J&J’s Dividend, Yielding 3.5%: What You Need to Know About Cash and Growth
December 10, 2012
category NVS , BRK/B , JNJ
from YCharts
(ARIA) ARIAD Pharmaceuticals Sees Data Published on Drug Candidate
December 05, 2012
ARIAD Pharmaceuticals (ARIA) recently announced the publishing of results from a phase I... Visit StockBlogHub to view complete post. Read More
category Biotechnology , Ariad Pharmaceuticals Inc , Novartis AG , and 11 more.
from Stock Blog Hub
How Big Pharma Might Get Its R&D Act Together
December 04, 2012
category NVS , SNY , MRK , and 2 more.
from YCharts
Pfizer, Stock Rising on Cost Cuts, Plans More Staff Layoffs
December 02, 2012
category NVS , AZN , ABT , and 2 more.
from YCharts
Accenture Life Sciences Study: Worst of Pharma’s Patent Cliff is Passing
November 29, 2012
category NVS , SNY , MRK , and 3 more.
from YCharts
If Only People Would Take Their Meds – Pharma Sales Might Double
November 27, 2012
category NVS , SNY , MRK , and 2 more.
from YCharts
Generics Maker Teva Pharmaceutical to Make Smaller Acquisitions, Chairman Says
November 21, 2012
category NVS , SNY , TEVA , and 2 more.
from YCharts
One Way, Allegedly, to Battle Generic Versions of Drugs: A Psychiatrist, Kickbacks & Antipsychotics
November 19, 2012
category NVS , TEVA
from YCharts
(WPI) Watson Pharmaceuticals Earns FDA Approval for Generic Sanctura XR
November 15, 2012
Watson Pharmaceuticals, Inc. (WPI) recently announced that it has gained US Food and Drug... Visit StockBlogHub to view complete post. Read More
category Allergan Inc/ , Mylan Inc/ , TEVA , and 15 more.
from Stock Blog Hub
Novartis Begins to Fix Manufacturing Problems
November 12, 2012
category NVS , JNJ
from YCharts
Pharma’s Off-Label Violations Not Limited to the U.S.: Glaxo’s U.K. Flap
November 12, 2012
category NVS , SNI , MRK , and 2 more.
from YCharts
Big Pharma on the Defensive: Sanofi Caves on Oncology-Drug, Halving Price – More to Come?
November 09, 2012
category NVS , REGN , SNI , and 3 more.
from YCharts
No-Go on Hepatitis Drug Patent in India: More Developing-Country Bad News for Big Pharma
November 05, 2012
category NVS , SNI , MRK , and 2 more.
from YCharts
Novartis Bullish Engulfing Formed
November 05, 2012
New York, November 5th (TradersHuddle.com) - Shares of Novartis AG ( NYSE:NVS ) ended the trading session higher by $0.06 or 0.1% from its previous close. Novartis' price action formed what is... Read More
from TradersHuddle.com
Company to Build Singapore Biotech Facility
November 01, 2012
Novartis (NYSE: NVS) is investing $500 million to develop its presence in Singapore... Read More
from Wealth Daily
More Quality Problems at Johnson & Johnson (Odious Details Omitted)
October 29, 2012
category NVS , JNJ , MRK , and 2 more.
from YCharts
Beat and Raise Quarter for Amgen – Analyst Blog
October 24, 2012
Amgen (AMGN) continued its strong performance in 2012 with third quarter earnings coming in at $1.66 per share, 23 cents above the Zacks Consensus Estimate and 19.4% above the year-ago period. Higher... Read More
category Zacks , Syndicated Content
from Money Morning
(ARE) Alexandria Real Estate Equities Pens New Lease Deals
October 23, 2012
Pasadena, California-based real estate investment trust (REIT), Alexandria Real Estate Equities,... Visit StockBlogHub to view complete post. Read More
category TMO , Glaxosmithkline plc , ABT , and 13 more.
from Stock Blog Hub
(MYL) Mylan in Neutral Lane
October 23, 2012
We are maintaining our Neutral recommendation on Mylan Inc. (MYL) with a target price of $26.00.... Visit StockBlogHub to view complete post. Read More
category Mylan Inc/ , TEVA , Sanofi/Aventis , and 9 more.
from Stock Blog Hub
Global Squeeze on Pharma Prices Just Won’t Ease Up: Canadians Iffy on Patents Extentions
October 22, 2012
category NVS , SNY , MRK , and 3 more.
from YCharts
(WPI) Watson Pharmaceuticals A Step Closer to Actavis
October 20, 2012
Watson Pharmaceuticals, Inc. (WPI) recently received a favorable vote from the Federal Trade... Visit StockBlogHub to view complete post. Read More
category Mylan Inc/ , Glaxosmithkline plc , TEVA , and 17 more.
from Stock Blog Hub
Ah, Geez, the Aussies, Too? Plush Patent Rights of Big Pharma Getting the Once-Over
October 19, 2012
category NVS , SNY , MRK , and 3 more.
from YCharts
Pharmaceutical Stocks Are All-of-a-Sudden Hot Again: Read About Drugs and Dividends
October 18, 2012
category NVS , T , MRK , and 4 more.
from YCharts
Pharma Industry Agrees to Price Cuts With Irish Government: More to Come?
October 17, 2012
category NVS , SNY , JNJ , and 3 more.
from YCharts
Don’t Call it Bribery – And Whatever it Was, Abbott Stopped Doing in (In India)
October 17, 2012
category NVS , SNY , MRK , and 3 more.
from YCharts
One Reason Novartis is Expected to Overtake Pfizer in Revenue: its Generics Business
October 16, 2012
category NVS , SNY , GSK , and 1 more.
from YCharts
Golly, Big Pharma, This Emerging Markets Strategy Isn’t Looking So Easy, Is It?
October 16, 2012
category NVS , MRK , GSK , and 2 more.
from YCharts
(ARIA) ARIAD Pharmaceuticals Seeks Ponatinib Approval
October 10, 2012
ARIAD Pharmaceuticals, Inc. (ARIA) recently completed the rolling submission of the New Drug... Visit StockBlogHub to view complete post. Read More
category Biotechnology , Ariad Pharmaceuticals Inc , NVS , and 13 more.
from Stock Blog Hub
(MYL) More Generic Launches at Mylan
October 09, 2012
Mylan Pharmaceuticals Inc., a subsidiary of Mylan Inc. (MYL), recently announced that it has... Visit StockBlogHub to view complete post. Read More
category Mylan Inc/ , Dr/ Reddy's Laboratories Limited , TEVA , and 9 more.
from Stock Blog Hub
< Previous 1 2 3 4 5 6 7 8 9
...
27 28 Next >
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates Bots go here